Structure Therapeutics, Inc. (GPCR)
20.44
+0.10
(+0.47%)
USD |
NASDAQ |
Nov 04, 13:41
Structure Therapeutics Total Return Price : 20.44 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 20.35 |
| November 02, 2026 | 20.47 |
| October 30, 2026 | 21.87 |
| October 29, 2026 | 21.94 |
| October 28, 2026 | 21.48 |
| October 27, 2026 | 21.55 |
| October 26, 2026 | 21.10 |
| October 23, 2026 | 21.19 |
| October 22, 2026 | 21.93 |
| October 21, 2026 | 22.01 |
| October 20, 2026 | 22.88 |
| October 19, 2026 | 22.01 |
| October 16, 2026 | 21.08 |
| October 15, 2026 | 22.19 |
| October 14, 2026 | 21.88 |
| October 13, 2026 | 22.31 |
| October 12, 2026 | 23.91 |
| October 09, 2026 | 25.54 |
| October 08, 2026 | 25.67 |
| October 07, 2026 | 26.68 |
| October 06, 2026 | 27.47 |
| October 05, 2026 | 27.59 |
| October 02, 2026 | 27.67 |
| October 01, 2026 | 28.98 |
| September 30, 2026 | 31.27 |
| Date | Value |
|---|---|
| September 29, 2026 | 32.69 |
| September 28, 2026 | 35.06 |
| September 25, 2026 | 35.93 |
| September 24, 2026 | 36.02 |
| September 23, 2026 | 35.95 |
| September 22, 2026 | 36.91 |
| September 21, 2026 | 36.81 |
| September 18, 2026 | 35.00 |
| September 17, 2026 | 35.10 |
| September 16, 2026 | 35.50 |
| September 15, 2026 | 38.95 |
| September 14, 2026 | 38.44 |
| September 11, 2026 | 38.66 |
| September 10, 2026 | 39.55 |
| September 09, 2026 | 41.23 |
| September 08, 2026 | 40.38 |
| September 04, 2026 | 47.34 |
| September 03, 2026 | 47.34 |
| September 02, 2026 | 47.80 |
| September 01, 2026 | 47.13 |
| August 31, 2026 | 45.91 |
| August 28, 2026 | 47.37 |
| August 27, 2026 | 49.22 |
| August 26, 2026 | 49.35 |
| August 25, 2026 | 49.92 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Eli Lilly & Co. | 1419.08 |
| Novo Nordisk A/S | 42.79 |
| Pfizer Inc. | 30.71 |
| Viking Therapeutics, Inc. | 27.66 |
| Liquidia Corp. | 48.92 |